Pulse Pressure Index as a Discriminator of Predicting the Cardiovascular Events in Hypertensive Patients Treated with Drugs Acting on Angiotensinogen-Angiotensin Pathway
Background: Pulse pressure index as a function of pulse pressure divided by systolic blood pressure served is a useful predictor of cardiovascular events. Objectives: Our aim was to assess the pulse pressure index as a discriminating variable of predicting cardiovascular events in untreated or hyper...
Saved in:
| Main Authors: | Marwan S. Al-Nime, Ismail I. Hussein, Yagub S. Saleh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Anbar
2019-06-01
|
| Series: | Al-Anbar Medical Journal |
| Subjects: | |
| Online Access: | https://amj.uoanbar.edu.iq/article_170879_ede6ed32f405035bcdd2127a19b882d9.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01) -
Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01) -
Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01) -
INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01) -
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)